-
1
-
-
45149118311
-
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
-
DOI 10.1038/nbt1407, PII NBT1407
-
Guerrini M, Beccati D, Shriver Z, et al. Oversulfated chondroitin sulfate is a major contaminant in heparin associated with adverse clinical events. Nature Biotechnology 2008; 26: 689-1675 (Pubitemid 351824692)
-
(2008)
Nature Biotechnology
, vol.26
, Issue.6
, pp. 669-675
-
-
Guerrini, M.1
Beccati, D.2
Shriver, Z.3
Naggi, A.4
Viswanathan, K.5
Bisio, A.6
Capila, I.7
Lansing, J.C.8
Guglieri, S.9
Fraser, B.10
Al-Hakim, A.11
Gunay, N.S.12
Zhang, Z.13
Robinson, L.14
Buhse, L.15
Nasr, M.16
Woodcock, J.17
Langer, R.18
Venkataraman, G.19
Linhardt, R.J.20
Casu, B.21
Torri, G.22
Sasisekharan, R.23
more..
-
2
-
-
44849115945
-
Contaminated heparin associated with adverse clinical events and activation of the contact system
-
Kishimoto TK, Viswanatan K, Ganguly T, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. New Engl J Med 2008; 358: 1-11.
-
(2008)
New Engl J Med
, vol.358
, pp. 1-11
-
-
Kishimoto, T.K.1
Viswanatan, K.2
Ganguly, T.3
-
3
-
-
70449599485
-
-
Accessed at: on January 12, 2009
-
Heparin Open Microphone Web Meeting, Meeting #2, Thursday, June 12, 2008 - 11:30 a.m. to 12:30 p.m.Eastern Time. Accessed at: "http://www.usp.org/ pdf/EN/hottopics/heparinPresentation.pdf " on January 12, 2009.
-
Heparin Open Microphone Web Meeting, Meeting #2, Thursday, June 12, 2008 - 11:30 A.m. to 12:30 P.m.Eastern Time
-
-
-
6
-
-
0024539192
-
Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-NMR spectroscopy
-
Neville GA, Mori F, Holme KR, et al. Monitoring the purity of pharmaceutical heparin preparations by high-field 1H-NMR spectroscopy. J Pharm Sci 1989; 78, 2: 101-104.
-
(1989)
J Pharm Sci
, vol.78
, Issue.2
, pp. 101-104
-
-
Neville, G.A.1
Mori, F.2
Holme, K.R.3
-
7
-
-
0025328109
-
Chemical composition, particle size range, and biological activity of some low molecular weight heparin derivatives
-
DOI 10.1002/jps.2600790414
-
Neville GA, Mori F, Racey TJ, et al. Chemical Composition, Particle Size Range, and Biological Activity of Some Low Molecular Weight Heparin Derivatives. J Pharm Sci 1990; 79: 339-343. (Pubitemid 20186334)
-
(1990)
Journal of Pharmaceutical Sciences
, vol.79
, Issue.4
, pp. 339-343
-
-
Neville, G.A.1
Mori, F.2
Racey, T.J.3
Rochon, P.4
Holme, K.R.5
Perlin, A.S.6
-
8
-
-
0034533546
-
Characterization of unfractionated heparin: Comparison of materials from the last 50 years
-
Mulloy B, Gray E, Barrowcliffe TW. Characterisation of unfractionated heparin: comparison of materials from the last 50 years. Thromb Haemost 2000; 84: 1052-1056. (Pubitemid 32014042)
-
(2000)
Thrombosis and Haemostasis
, vol.84
, Issue.6
, pp. 1052-1056
-
-
Mulloy, B.1
Gray, E.2
Barrowcliffe, T.W.3
-
9
-
-
0036744549
-
Dermatan sulfate: New functions from an old glycosaminoglycan
-
Trowbridge JM, Gallo RL. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology 2002; 12: 117-125.
-
(2002)
Glycobiology
, vol.12
, pp. 117-125
-
-
Trowbridge, J.M.1
Gallo, R.L.2
-
10
-
-
0031938089
-
Pharmacological actions of Sulodexide
-
Ofosu FA, Pharmacological actions of Sulodexide. Sem Thromb Hemost 1998; 24: 127-138.
-
(1998)
Sem Thromb Hemost
, vol.24
, pp. 127-138
-
-
Ofosu, F.A.1
-
11
-
-
1642342232
-
Structural and conformational aspects of the anticoagulant and antithrombotic activity of heparin and dermatan sulfate
-
DOI 10.2174/1381612043452794
-
Casu B, Guerrini M, Torri G. Structural and conformational aspects of the anticoagulant and antithrombotic activity of heparin and dermatan sulfate. Curr Pharmac Des 2004; 10: 939-949. (Pubitemid 38380073)
-
(2004)
Current Pharmaceutical Design
, vol.10
, Issue.9
, pp. 939-949
-
-
Casu, B.1
Guerrini, M.2
Torri, G.3
-
12
-
-
0027753111
-
Structure and contribution to the HCII-mediated inhibition of thrombin of naturally oversulfated sequences of dermatan sulphate
-
Mascellani G, Liverani L, Bianchini P, et al. Structure and contribution to the HCII-mediated inhibition of thrombin of naturally oversulfated sequences of dermatan sulphate. Biochem J. 1993; 296: 639-659.
-
(1993)
Biochem J
, vol.296
, pp. 639-659
-
-
Mascellani, G.1
Liverani, L.2
Bianchini, P.3
-
13
-
-
0001742164
-
Active site of dermatan sulfate for heparin cofactor II. Isolation of a nonasaccharide fragment containing four disaccaride sequences [α-L-iduronic acid 2-O-sulfate (1,3)-β-D-N-acethylglucosamine 4-sulfate]
-
Mascellani G, Liverani L, Prete A, et al. Active site of dermatan sulfate for heparin cofactor II. Isolation of a nonasaccharide fragment containing four disaccaride sequences [α-L-iduronic acid 2-O-sulfate (1,3)-β-D-N- acethylglucosamine 4-sulfate]. J Carbohydr Chem 1995;14: 1165-1177.
-
(1995)
J Carbohydr Chem
, vol.14
, pp. 1165-1177
-
-
Mascellani, G.1
Liverani, L.2
Prete, A.3
-
14
-
-
0030271870
-
Active site for heparan cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II
-
Mascellani G, Liverani L, Parma B, et al. Active site for heparan cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II. Thromb Res 1996; 84: 21-32.
-
(1996)
Thromb Res
, vol.84
, pp. 21-32
-
-
Mascellani, G.1
Liverani, L.2
Parma, B.3
-
15
-
-
0033566956
-
Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1β
-
Koopmann W, Ediriwickrema C, Krangel MS. Structure and function of glycosamiglycan binding site of chemokine macrophage-inflammatory protein-1β. J Immunol 1999; 163: 2120-2127. (Pubitemid 29382218)
-
(1999)
Journal of Immunology
, vol.163
, Issue.4
, pp. 2120-2127
-
-
Koopmann, W.1
Ediriwickrema, C.2
Krangel, M.S.3
-
16
-
-
0032561306
-
Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function
-
DOI 10.1074/jbc.273.43.28116
-
Penc SF, Pomahac B, Winkler T, et al. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J Biol Chem 1998; 273: 28116-28121. (Pubitemid 28496107)
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.43
, pp. 28116-28121
-
-
Penc, S.F.1
Pomahac, B.2
Winkler, T.3
Dorschner, R.A.4
Eriksson, E.5
Herndon, M.6
Gallo, R.L.7
-
19
-
-
70449606729
-
Non anticoagulant heparan sulfate, process for extraction from organs and pharmaceutical composition thereof
-
WO8904328. EP 0386053B1. Trough Esp@cenet; through CA 112, 091793/11P
-
Mascellani G, Bianchini P. Non anticoagulant heparan sulfate, process for extraction from organs and pharmaceutical composition thereof. WO8904328. EP 0386053B1. 1994. Trough Esp@cenet; through CA 112, 091793/11P.
-
(1994)
-
-
Mascellani, G.1
Bianchini, P.2
-
21
-
-
0017189425
-
Formation of anhydrosugars in the chemical depolymerization of heparin
-
Shively JE, Conrad HE. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 1976; 15: 3932-3942
-
(1976)
Biochemistry
, vol.15
, pp. 3932-3942
-
-
Shively, J.E.1
Conrad, H.E.2
-
22
-
-
0017086828
-
Nearest neighbor analysis of heparin: Identification and quantitation of the products formed by selective depolymerization procedures
-
and ibidem. Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures. Biochemistry 1976; 15: 3943-3950.
-
(1976)
Biochemistry
, vol.15
, pp. 3943-3950
-
-
-
23
-
-
70449599486
-
Mucopolysaccharides having biological properties, preparation and method of use
-
US 4,500519 Through CA 98, P132290c
-
Lormeau JC, Petitou M, Choay J. Mucopolysaccharides having biological properties, preparation and method of use. US 4,500519. 1985. Through CA 98, P132290c.
-
(1985)
-
-
Lormeau, J.C.1
Petitou, M.2
Choay, J.3
-
24
-
-
84873332528
-
Method for determining specific groups constituting heparins or low molecular weight heparins
-
Patent application US 2005/0119477 A1. Through CA 142, 89363P
-
Mourier P,Viskov C. Method for determining specific groups constituting heparins or low molecular weight heparins. Patent application US 2005/0119477 A1. Through CA 142, 89363P.
-
-
-
Mourier, P.1
Viskov, C.2
-
25
-
-
0011801358
-
Analytical techniques for studying structures of DS and LMW DS
-
Volpi N, Mascellani G, Bianchini P, et al. Analytical techniques for studying structures of DS and LMW DS. Il Farmaco 1992; 47: 841-853.
-
(1992)
Il Farmaco
, vol.47
, pp. 841-853
-
-
Volpi, N.1
Mascellani, G.2
Bianchini, P.3
-
26
-
-
0020108082
-
Further characterization of the antithrombin-binding sequence in heparin
-
Thunberg L, Bäckström G, Lindahl U. Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res 1982; 100: 393-410.
-
(1982)
Carbohydr Res
, vol.100
, pp. 393-410
-
-
Thunberg, L.1
Bäckström, G.2
Lindahl, U.3
-
27
-
-
0020544564
-
The antithrombin binding sequence in heparin. Identification of an essential 6O-sulfate group
-
Lindahl U, Bäckström G, Thunberg L. The antithrombin binding sequence in heparin. Identification of an essential 6O-sulfate group. J Biol Chem 1983; 258: 9826-9830.
-
(1983)
J Biol Chem
, vol.258
, pp. 9826-9830
-
-
Lindahl, U.1
Bäckström, G.2
Thunberg, L.3
-
28
-
-
70449594738
-
Process for oxidizing UFH and detecting presence of glycoserine
-
US 2005/0215519; Through CA 143, 353287/19 Patent 20051225
-
Mourier P, Viskov C. Process for oxidizing UFH and detecting presence of glycoserine. US 2005/0215519; Through CA 143, 353287/19 Patent 20051225.
-
-
-
Mourier, P.1
Viskov, C.2
-
29
-
-
0033215151
-
'Linkage region' sequences of heparins and heparan sulfates: Detection and quantification by nuclear magnetic resonance spectroscopy
-
DOI 10.1006/abio.1999.4230
-
Iacomini M, Casu B, Guerrini M, et al. Linkage region of heparin and heparan sulfate: detection and quantification by Nuclear magnetic resonance spectroscopy. Anal Biochem 1999; 274: 50-58. (Pubitemid 29466354)
-
(1999)
Analytical Biochemistry
, vol.274
, Issue.1
, pp. 50-58
-
-
Iacomini, M.1
Casu, B.2
Guerrini, M.3
Naggi, A.4
Pirola, A.5
Torri, G.6
-
30
-
-
44949287958
-
Base catalyzed conversion of the α-L-galacturonic acid, and related reactions
-
Rey N, Perlin AS, Base catalyzed conversion of the α-L-galacturonic acid, and related reactions. Carbohydr. Res. 1990; 200: 437-447.
-
(1990)
Carbohydr. Res.
, vol.200
, pp. 437-447
-
-
Rey, N.1
Perlin, A.S.2
-
31
-
-
33847256557
-
Characterization of di- And monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1,6-anhydro-β-d-glucosamine or N-sulfated 1,6-anhydro-β-d-mannosamine residues
-
DOI 10.1016/j.carres.2006.12.010, PII S0008621506005702
-
Mascellani G, Guerrini M, Torri G, et al. Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1,6-anhy dro-β-D-glucosamine or N-sulfated 1,6-anhydro- β-D-mannosamine residues. Carbohydr Res 2007; 342: 835-842. (Pubitemid 46321485)
-
(2007)
Carbohydrate Research
, vol.342
, Issue.6
, pp. 835-842
-
-
Mascellani, G.1
Guerrini, M.2
Torri, G.3
Liverani, L.4
Spelta, F.5
Bianchini, P.6
-
32
-
-
8444233148
-
Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases
-
DOI 10.1016/j.ab.2004.06.020, PII S0003269704005366
-
Mourier P, Viskov C. Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethyl ammonium dynamically coated stationary phases. Anal Biochem 2004; 332: 299-313. (Pubitemid 39485739)
-
(2004)
Analytical Biochemistry
, vol.332
, Issue.2
, pp. 299-313
-
-
Mourier, P.A.J.1
Viskov, C.2
-
33
-
-
1642404152
-
NMR identification of structural environments for 2,3 or 2,3,6 trisulfated glucosamine residues in heparin with high and no affinity for antithrombin
-
Bisio A, Guerrini M, Yates EA, et al. NMR identification of structural environments for 2,3 or 2,3,6 trisulfated glucosamine residues in heparin with high and no affinity for antithrombin. Glycoconj J 1997; 14: S89.
-
(1997)
Glycoconj J
, vol.14
-
-
Bisio, A.1
Guerrini, M.2
Yates, E.A.3
-
34
-
-
55549136766
-
Antithrombin- Binding octasaccharides and role of extension of the active pentasaccharide sequence in the specificity and strength of interaction
-
Guerrini M, Guglieri S, Casu B, et al. Antithrombin- binding octasaccharides and role of extension of the active pentasaccharide sequence in the specificity and strength of interaction. J Biol Chem 2008; 283: 26662-26675.
-
(2008)
J Biol Chem
, vol.283
, pp. 26662-26675
-
-
Guerrini, M.1
Guglieri, S.2
Casu, B.3
-
35
-
-
11844304289
-
Structural characterization of human liver heparan sulfate
-
DOI 10.1016/j.bbagen.2004.09.007, PII S0304416504002405
-
Vongchan P, Warda M, Toida T, et al. Structural characterization of human liver heparan sulfate. Biochim Biophys Acta 2005; 1721: 1-8. (Pubitemid 40093506)
-
(2005)
Biochimica et Biophysica Acta - General Subjects
, vol.1721
, Issue.1-3
, pp. 1-8
-
-
Vongchan, P.1
Warda, M.2
Toyoda, H.3
Toida, T.4
Marks, R.M.5
Linhardt, R.J.6
-
36
-
-
0022365027
-
Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities
-
Bianchini P, Osima B, Parma B, et al. Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities. Arzneim-Forsch/Drug Res 1985; 35: 1215-1219. (Pubitemid 16240616)
-
(1985)
Arzneimittel-Forschung/Drug Research
, vol.35
, Issue.8
, pp. 1215-1219
-
-
Bianchini, P.1
Osima, B.2
Parma, B.3
|